Identification of GDC-0810 (ARN-810), an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) that Demonstrates Robust Activity in Tamoxifen-Resistant Breast Cancer Xenografts 论文

2015Journal of Medicinal Chemistry引用 247
DOI
Estrogen and related hormone effectsComputational Drug Discovery MethodsHER2/EGFR in Cancer Research
Computational Drug Discovery MethodsEstrogen and related hormone effectsHER2/EGFR in Cancer Research
相关技术:Computational Drug Discovery Methods
关系图谱

Identification of GDC-0810 (ARN-810), an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) that Demonstrates Robust Activity in Tamoxifen-Resistant Breast Cancer Xenografts · 相关事件

暂无数据